Preliminary data from the phase I/II study of TP-3654, a selective oral PIM1 kinase inhibitor, in patients with myelofibrosis previously treated with or ineligible for JAK inhibitor therapy Meeting Abstract
| Authors: | El Chaer, F.; McCloskey, J.; Rein, L. A. M.; Brown, R. A.; Green, S. D.; Pu, J. J.; Shirane, S.; Shimoda, K.; Ichii, M.; Yuda, J.; Scandura, J.; Kabir, S.; Foulks, J. M.; Mei, J.; Yang, H.; Wade, M.; Stapinski, C.; Lebedinsky, C.; Rampal, R. K. |
| Abstract Title: | Preliminary data from the phase I/II study of TP-3654, a selective oral PIM1 kinase inhibitor, in patients with myelofibrosis previously treated with or ineligible for JAK inhibitor therapy |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 594 |
| End Page: | 595 |
| Language: | English |
| ACCESSION: | WOS:000893223200240 |
| DOI: | 10.1182/blood-2022-159086 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
